COVID-19 Vaccines, Healthcare Policies and Stock Markets: Are There Winners and Losers?

References

• Piñeiro-Chousa J, Lopez-Cabarcos MA, Quiñoá-Piñeiro L, Pérez Pico A. US biopharmaceutical companies’ stock market reaction to the COVID-19 pandemic. Understanding the concept of the ‘paradoxical spiral’ from a sustainability perspective. Technol Forecast Soc Change. 2022;175:121365. doi:10.1016/j.techfore.2021.121365
   PubMed Web of Science ®Google Scholar
• Baker SR, Bloom N, Davis SJ, Kost KJ, Sammon MC. The unprecedented stock market impact of COVID-19. National Bureau of Economic Research Working Paper Series; 2020:26945.
   Google Scholar
• Zaremba A, Kizys R, Aharon DY, Demir E. Infected markets: novel coronavirus, government interventions, and stock return volatility around the globe. Finance Res Lett. 2020;35:101597. doi:10.1016/j.frl.2020.101597
   PubMed Web of Science ®Google Scholar
• Yu H, Chu W, Ding YA, Zhao X. Risk contagion of global stock markets under COVID‐19: a network connectedness method. Accoun Finance. 2021;61(4):5745–5782. doi:10.1111/acfi.12775
   Web of Science ®Google Scholar
• Donadelli M, Kizys R, Riedel M. Dangerous infectious diseases: bad news for main street, good news for Wall street? J Financial Markets. 2017;35:84–103. doi:10.1016/j.finmar.2016.12.003
   Web of Science ®Google Scholar
• World Health Organization. Global Vaccine Market Report. Geneva: World Health Organization; 2022.
   Google Scholar
• Chatjuthamard P, Jindahra P, Sarajoti P, Treepongkaruna S. The effect of COVID‐19 on the global stock market. Accoun Finance. 2021;61(3):4923–4953. doi:10.1111/acfi.12838
   Web of Science ®Google Scholar
• Baek S, Lee KY. The risk transmission of COVID-19 in the US stock market. Appl Econ. 2021;53(17):1976–1990. doi:10.1080/00036846.2020.1854668
   Web of Science ®Google Scholar
• Cao KH, Li Q, Liu Y, Woo CK. Covid-19’s adverse effects on a stock market index. Appl Econ Lett. 2021;28(14):1157–1161. doi:10.1080/13504851.2020.1803481
   Web of Science ®Google Scholar
• Xu L, Chen J, Zhang X, Zhao J. COVID‐19, public attention and the stock market. Accoun Finance. 2021;61(3):4741–4756. doi:10.1111/acfi.12734
   Web of Science ®Google Scholar
• Ozik G, Sadka R, Shen S. Flattening the illiquidity curve: retail trading during the COVID-19 lockdown. J Financial Quant Anal. 2021;56(7):2356–2388. doi:10.1017/S0022109021000387
   Web of Science ®Google Scholar
• Liu H, Wang Y, He D, Wang C. Short term response of Chinese stock markets to the outbreak of COVID-19. Appl Econ. 2020;52(53):5859–5872. doi:10.1080/00036846.2020.1776837
   Web of Science ®Google Scholar
• Mittal S, Sharma D. The impact of COVID-19 on stock returns of the Indian healthcare and pharmaceutical sector. Australas Account Bus Finance J. 2021;15(1):5–21. doi:10.14453/aabfj.v15i1.2
   Web of Science ®Google Scholar
• Phuong LCM. How COVID-19 affects the share price of Vietnam’s pharmaceutical industry: event study method. Entrepreneurship Sustain Issues. 2021;8(4):250. doi:10.9770/jesi.2021.8.4(14)
   Web of Science ®Google Scholar
• Varma Y, Venkataramani R, Kayal P, Maiti M. Short-term impact of COVID-19 on Indian stock market. J Risk Finance Manage. 2021;14(11):558. doi:10.3390/jrfm14110558
   Web of Science ®Google Scholar
• Díaz RF. El sector farmacéutico: eficiencia, rentabilidad y COVID-19 [Dissertation]. Madrid: Universidad Nacional de Educación a Distancia; 2023.
   Google Scholar
• Goodell JW. COVID-19 and finance: agendas for future research. Finance Res Lett. 2020;35:101512. doi:10.1016/j.frl.2020.101512
   PubMed Web of Science ®Google Scholar
• Hwang TJ. Stock market returns and clinical trial results of investigational compounds: an event study analysis of large biopharmaceutical companies. PLoS One. 2013;8(8):e71966. doi:10.1371/journal.pone.0071966
   PubMed Web of Science ®Google Scholar
• Perez-Rodríguez JV, Valcárcel BG. Do product innovation and news about the R&D process produce large price changes and overreaction? The case of pharmaceutical stock prices. Appl Econ. 2012;44(17):2217–2229. doi:10.1080/00036846.2011.562172
   Web of Science ®Google Scholar
• De Schrijver J. Analysis of stock market reactions to FDA and EMEA announcements [dissertation]. Ghent: Ghent University; 2013.
   Google Scholar
• Heyden KJ, Heyden T. Market reactions to the arrival and containment of COVID-19: an event study. Finance Res Lett. 2021;38:101745. doi:10.1016/j.frl.2020.101745
   PubMed Web of Science ®Google Scholar
• Ichev R, Marinč M. Stock prices and geographic proximity of information: evidence from the Ebola outbreak. Int Rev Financial Anal. 2018;56:153–166. doi:10.1016/j.irfa.2017.12.004
   Web of Science ®Google Scholar
• Haroon O, Rizvi SAR. COVID-19: media coverage and financial markets behavior—a sectoral inquiry. J Behav Exp Finance. 2020;27:100343. doi:10.1016/j.jbef.2020.100343
   PubMed Web of Science ®Google Scholar
• Alam MM, Wei H, Wahid AN. COVID‐19 outbreak and sectoral performance of the Australian stock market: an event study analysis. Aust Econ Pap. 2021;60(3):482–495. doi:10.1111/1467-8454.12215
   PubMed Web of Science ®Google Scholar
• Behera C, Rath BN. The COVID-19 pandemic and Indian pharmaceutical companies: an event study analysis. Bulletin Monet Econ Banking. 2021;24:1–14. doi:10.21098/bemp.v24i0.1483
   Google Scholar
• Alcaide González MA, De la Poza Plaza E, Guadalajara Olmeda N. How has the announcement of the Covid-19 pandemic and vaccine impacted the market? Econ Res Ekon Istraz. 2022;35(1):5615–5631. doi:10.1080/1331677X.2022.2033129
   Web of Science ®Google Scholar
• Zhang LC. Event study: the influence of COVID-19 research and development news on pharmaceutical and biotech companies. Working Paper. Ann Arbor: University of Michigan; 2021.
   Google Scholar
• Casault S, Groen AJ, Linton JD. Improving value assessment of high-risk, high-reward biotechnology research: the role of ‘thick tails’. N Biotechnol. 2014;31(2):172–178. doi:10.1016/j.nbt.2013.12.001
   PubMed Web of Science ®Google Scholar
• Brenner M. The sensitivity of the efficient market hypothesis to alternative specifications of the market model. J Finance. 1979;34(4):915–929. doi:10.1111/j.1540-6261.1979.tb03444.x
   Web of Science ®Google Scholar
• Sorokina N, Booth DE, Thornton JH Jr. Robust methods in event studies: empirical evidence and theoretical implications. J Data Sci. 2013;11:575–606. doi:10.6339/JDS.2013.11(3).1166
   Google Scholar
• Armitage S. Event study methods and evidence on their performance. J Eco Survey. 1995;9(1):25–52. doi:10.1111/j.1467-6419.1995.tb00109.x
   Google Scholar
• Yahoo finance. Homepage on the Internet; 2023. Available from: https://www.yahoo.com/author/yahoo-finance/. Accessed April 14, 2023.
   Google Scholar
• Kothari SP, Warner JB. Econometrics of event studies. In: Espen Eckbo B, editor. Handbook of Empirical Corporate Finance. Amsterdam: Elsevier; 2007:3–36.
   Google Scholar
• Brown SJ, Warner JB. Using daily stock returns: the case of event studies. J Financial Eco. 1985;14(1):3–31. doi:10.1016/0304-405X(85)90042-X
   Web of Science ®Google Scholar
• Theodossiou AK, Theodossiou P, Yaari U. Beta estimation with stock return outliers: the case of US pharmaceutical companies. SSRN Electro J. 2009. doi:10.2139/ssrn.1410371
   Google Scholar
• Sun Y, Wu M, Zeng X, Peng Z. The impact of COVID-19 on the Chinese stock market: sentimental or substantial? Finance Res Lett. 2021;38:101838. doi:10.1016/j.frl.2020.101838
   PubMed Web of Science ®Google Scholar
• He P, Sun Y, Zhang Y, Li T. COVID–19’s impact on stock prices across different sectors—An event study based on the Chinese stock market. Emerg Mark Finance Trade. 2020;56(10):2198–2212. doi:10.1080/1540496X.2020.1785865
   Web of Science ®Google Scholar
• Kesselheim AS, Darrow JJ, Kulldorff M, et al. An overview of vaccine development, approval, and regulation, with implications for COVID-19: analysis reviews the food and drug administration’s critical vaccine approval role with implications for COVID-19 vaccinesHealth. Affairs. 2021;40(1):25–32.
   PubMed Web of Science ®Google Scholar
• Wouters OJ, Shadlen KC, Salcher-Konrad M, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023–1034. doi:10.1016/S0140-6736(21)00306-8
   PubMed Web of Science ®Google Scholar
• OECD. Data; 2023. Available from: https://data.oecd.org/. Accessed April 24, 2023.
   Google Scholar
• Tinari S, Riva C. Covid-19: whatever happened to the Novavax vaccine? BMJ. 2021;375. doi:10.1136/bmj.n2965
   PubMedGoogle Scholar
• Pharmaceutical Technology. homepage on the the internet. Available from: https://www.pharmaceutical-technology.com/features/top-ten-pharma-companies-in-2020/. Accessed March 28, 2022.
   Google Scholar
• World Health Organization (WHO). Coronavirus disease (COVID-19): vaccines; 2022b. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines. Accessed April 18, 2023.
   Google Scholar